- feeds
- popular
- recent
- reader
- about
- story
- technologies
- what is rss
- connect
- dmca
- contact
- Feed Preview News – San Diego Biotechnology Network
ASH: New Gilead-Arcellx data build CAR-T’s case against Carvykti in advanced multiple myeloma
Arcellx has shared several data cuts on anito-cel, a CAR-T being developed with Gilead’s Kite Pharma to treat relapsed or refractory multiple myeloma (RRMM). After seeing the data, analysts und...
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
SAN MATEO, Calif.–(BUSINESS WIRE)—- $BGNE #BeiGene–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range o...
Orca Bio to Present Clinical Data on Its High-Precision Cel...pies at the 66th American Society of Hematology Annual Meeting
MENLO PARK, Calif.–(BUSINESS WIRE)–Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that new c...
Auron to Present New Preclinical Data for AUTX-703 at 2024 ASH Meeting
NEWTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) — Auron Therapeutics, a biotechnology company focused on developing next-generation targeted therapies by identifying and inhibiting the oncogenic ...
Tessera Therapeutics to Present New Preclinical Data From I...pies at the 66th American Society of Hematology Annual Meeting
SOMERVILLE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) — Tessera Therapeutics, a biotechnology company pioneering a new approach to genome engineering through the development of its Gene Writing™ ...
Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results
SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degener...
The Brains Behind Today’s AI Revolution
Professor Terry Sejnowski helped pioneer a foundation that set the stage for the current surge of AI advancements. In this interview he discusses the path of brain research that led to today’s ...
https://sdbn.org/san-diego-biotech-news/2024/11/05/the-brains-behind-todays-ai-revolution/
UC San Diego Researchers Develop Low-Cost, Scalable Passive Sensors
New research from UC San Diego proves that wireless, battery-free sensing is possible at low costs without any specialized equipment. Click here to view original post Click Here to Publish/Featur...
Explaining Science Through Dance
Science can be difficult to explain to the public. Explaining a theoretical science concept to high school students requires a new way of thinking altogether, which is precisely what researchers ...
https://sdbn.org/san-diego-biotech-news/2024/11/05/explaining-science-through-dance/
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024
Core Illumina revenue of $1.1 billion for Q3 2024, down 2% from Q3 2023 and on a constant currency basis Core Illumina GAAP operating margin of 68.6% and non-GAAP operating margin of 22.6% for Q3...
Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
SAN DIEGO, Nov. 4, 2024 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a biopharmaceutical company with two programs in ongoing clinical trials an...
Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE
Donidalorsen will be a first-in-class RNA-targeted medicine for hereditary angioedema, assuming approval Donidalorsen PDUFA date set for August 21, 2025 Donidalorsen has the potential to be Ionis...
858 Therapeutics and OpenBench Launch Small Molecule Drug Discovery Collaboration
SAN DIEGO & SAN FRANCISCO–(BUSINESS WIRE)–858 Therapeutics and OpenBench today announced a collaboration to discover small molecule inhibitors using OpenBench’s structure-based machine lear...
Neurocrine Biosciences Presents Breadth of Data Demonstrati...sia Following Treatment With INGREZZA® (valbenazine) Capsules
Findings Presented at the 2024 Psych Congress Include Data From More Than 300 Patients SAN DIEGO, Nov. 4, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) presented data from mor...
Neurocrine Biosciences Presents New Data on INGREZZA® (val...rm Study Participants Achieved Remission of Tardive Dyskinesia
SAN DIEGO, Nov. 4, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) presented data from the long-term KINECT®-4 study demonstrating tardive dyskinesia remission in nearly 60% of...
Viking’s oral obesity med sails ahead, posting 6.8% weight loss for highest dose in phase 1
Viking Therapeutics is rowing its longboat toward the front of the oral obesity therapy race, posting detailed phase 1 data that suggest its dual agonist of GLP-1 and GIP can hold its own in a
At ASHG, Illumina to Share Updates to Sequencing, Proteomics, and Single-Cell Technologies
Ahead of the 2024 American Society of Human Genetics annual meeting, Illumina has announced that it will provide updates on its whole-genome sequencing, proteomics, and single-cell technologies a...
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
SAN DIEGO, Nov. 03, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advan...
U.S. Department of Energy Awards UC San Diego $1.35 Million for Fusion Research
Fusion researchers at the University of California San Diego received $1.35 million from DOE’s Advanced Research Projects Agency-Energy. Known as a Creating Hardened And Durable fusion first Wa...
CalIT2 Workshop Looks to the Future of Health and Medicine
Throughout the day-long event, participants exchanged views on current issues in health and medicine, from addiction to hospital cybersecurity. Click here to view original post Click Here to Publ...
Kymera zeros in on immunology, seeks partners for cancer candidates
Kymera Therapeutics is pivoting focus from oncology to immunology, with plans to only develop cancer programs beyond phase 1 studies via partnerships. The Watertown, Massachusetts-based biotech i...
Suzanne Page named Salk Institute’s Chief Operating Officer
LA JOLLA—The Salk Institute has appointed Suzanne Page as Vice President and Chief Operating Officer (COO). She assumed the position on October 14, succeeding Kim Witmer, who retired after serv...
UC San Diego Part of National Hub for Large-scale Neuromorphic Computing
Bioengineering professor Gert Cauwenberghs at the University of California San Diego is one of four researchers leading a new hub that will provide access to open and heterogeneous neuromorphic c...
Blanchard Celebrates 45 Years of Empowering Leadership and Organizational Success
SAN DIEGO, Nov. 1, 2024 /PRNewswire/ — Blanchard®, a global pioneer in leadership development, consulting, and coaching, proudly announces the celebration of its 45-year anniversary. Ken and M...
UC San Diego’s Data Planet Initiative Marks Next Phase of Growth and Leadership
As the world faces challenges from climate change to public health, data-intensive solutions have become more significant. In light of this, the Data Planet Initiative at the Hal?c?o?lu Data Scie...
Skye Bioscience to Announce Third Quarter 2024 Results
SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metab...
NGS Sample Preparation Taking the Pain Out of Painstaking
Although next-generation sequencing (NGS) keeps giving—exploring the human genome and revolutionizing our knowledge of health and disease—it needs to take a little, too. At the very least, NG...
Omics Data Analysis: A Range of Options
We resent it when preliminary or ancillary work occupies so much of our attention that our real work, or what we consider to be our real work, recedes. No less a figure than Enrico Fermi,
https://sdbn.org/san-diego-biotech-news/2024/11/01/omics-data-analysis-a-range-of-options/
Improving the Manufacture of mRNA Biologics
The success of the mRNA-based vaccines against SARS-CoV-2 merely hint at the healthcare implications of mRNA technology. More mRNA-based vaccines are in the works, as are mRNA-based therapeutics ...
https://sdbn.org/san-diego-biotech-news/2024/11/01/improving-the-manufacture-of-mrna-biologics/
Biotech Networks Speed Networking San Diego December 10th 2024
Biotech Networks is hosting Scientific Speed Networking in San Diego Tuesday December 10th 2024, it’s a great chance for life science professionals to make connections before the holidays. W...